Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Foghorn Therapeutics Inc. | 400,000 | reported | 23 Feb 2026 | tx 1+400,000 |
| IOVANCE BIOTHERAPEUTICS, INC. | 67,546 | reported | 13 Jun 2025 | tx 17+622,508−100,000 |
| Tvardi Therapeutics, Inc. | 13,500 | reported | 01 Feb 2024 | tx 4+319,500−5,488 |
| RIGEL PHARMACEUTICALS INC | 0 | reported | 03 Nov 2017 | tx 38+2,152,913−400,004 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 23 Feb 2026 | GRANT_AWARD | Foghorn Therapeutics Inc. | 400,000 | 5.75 USD | deriv |
| 13 Jun 2025 | GRANT_AWARD | IOVANCE BIOTHERAPEUTICS, INC. | 67,546 | 0.00 USD | deriv |
| 12 Nov 2024 | SALE | IOVANCE BIOTHERAPEUTICS, INC. | 50,000 | 10.06 USD | |
| 12 Nov 2024 | EXERCISE | IOVANCE BIOTHERAPEUTICS, INC. | 50,000 | 7.45 USD | |
| 12 Nov 2024 | EXERCISE | IOVANCE BIOTHERAPEUTICS, INC. | 50,000 | 0.00 USD | deriv |
| 11 Jun 2024 | GRANT_AWARD | IOVANCE BIOTHERAPEUTICS, INC. | 49,303 | 0.00 USD | deriv |
| 01 Mar 2024 | GRANT_AWARD | IOVANCE BIOTHERAPEUTICS, INC. | 50,000 | 0.00 USD | deriv |
| 08 Feb 2023 | SALE | Tvardi Therapeutics, Inc. | 5,488 | 0.53 USD | |
| 01 Feb 2024 | GRANT_AWARD | Tvardi Therapeutics, Inc. | 13,500 | 0.00 USD | |
| 06 Jun 2023 | GRANT_AWARD | IOVANCE BIOTHERAPEUTICS, INC. | 51,955 | 0.00 USD | deriv |
| 01 Mar 2023 | GRANT_AWARD | Tvardi Therapeutics, Inc. | 81,000 | 0.00 USD | deriv |
| 12 Sept 2022 | GRANT_AWARD | Tvardi Therapeutics, Inc. | 225,000 | 0.00 USD | deriv |
| 10 Jun 2022 | GRANT_AWARD | IOVANCE BIOTHERAPEUTICS, INC. | 51,204 | 0.00 USD | deriv |
| 31 May 2022 | PURCHASE | IOVANCE BIOTHERAPEUTICS, INC. | 7,500 | 6.75 USD | |
| 29 Jun 2021 | GRANT_AWARD | IOVANCE BIOTHERAPEUTICS, INC. | 35,000 | 0.00 USD | deriv |
| 08 Jun 2020 | GRANT_AWARD | IOVANCE BIOTHERAPEUTICS, INC. | 35,000 | 0.00 USD | deriv |
| 10 Jun 2019 | GRANT_AWARD | IOVANCE BIOTHERAPEUTICS, INC. | 35,000 | 0.00 USD | deriv |
| 17 Jul 2018 | GRANT_AWARD | IOVANCE BIOTHERAPEUTICS, INC. | 35,000 | 0.00 USD | deriv |
| 03 Nov 2017 | SALE | RIGEL PHARMACEUTICALS INC | 100,000 | 3.90 USD | |
| 03 Nov 2017 | EXERCISE | RIGEL PHARMACEUTICALS INC | 100,000 | 2.14 USD | |
| 03 Nov 2017 | EXERCISE | RIGEL PHARMACEUTICALS INC | 100,000 | 0.00 USD | deriv |
| 01 Jun 2017 | GRANT_AWARD | IOVANCE BIOTHERAPEUTICS, INC. | 35,000 | 0.00 USD | deriv |
| 19 Apr 2017 | GRANT_AWARD | RIGEL PHARMACEUTICALS INC | 62,500 | 0.00 USD | deriv |
| 19 Apr 2017 | GRANT_AWARD | RIGEL PHARMACEUTICALS INC | 150,000 | 0.00 USD | deriv |
| 02 Feb 2017 | GRANT_AWARD | RIGEL PHARMACEUTICALS INC | 150,000 | 0.00 USD | deriv |